Dr. Guillermo Garcia-Manero

Articles by Dr. Guillermo Garcia-Manero

Investigational Drug Combination Could Address Unmet Need in TP53-Positive MDS

June 19th 2020

The phase 3 trial evaluating eprenetapopt plus Vidaza completed enrollment recently, and could lead to a new standard of care with positive results, according to Dr. Guillermo Garcia-Manero.

Latest Updated Articles

Investigational Drug Combination Could Address Unmet Need in TP53-Positive MDS
Published: June 19th 2020 | Updated:

Dr. Guillermo Garcia-Manero

Articles by Dr. Guillermo Garcia-Manero

Investigational Drug Combination Could Address Unmet Need in TP53-Positive MDS

Latest Updated Articles

Trending on CURE

Peritoneal Mesothelioma Survivor Shares Ongoing Reality of Survivorship

SUNRiSE-1 Participant Shares Insights on Bladder Cancer Education

What Does a Stage 2 Prostate Cancer Diagnosis Mean for Me?

Fertility Preservation During Breast Cancer: ‘I Would Do It All Again’